Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study.
Lu YuHaibo WangDarko MilijkovicXiaojun HuangQian JiangPublished in: BMC cancer (2018)
Chinese Clinical Trial Registry ( http://www.chictr.org.cn ): ChiCTR-OCH-11001699 .